ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Insilico used AI to develop rentosertib, a drug candidate for a rare lung disease. Early data suggests rentosertib could also slow aging, according to the company. The drug targets a chronic lung condition.
Tap to vote and see what everyone thinks.
Summary by ByteBrief